These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 9656829
41. Loss of vision in Gaucher's disease and its reversal by enzyme-replacement therapy. vom Dahl S, Niederau C, Häussinger D. N Engl J Med; 1998 May 14; 338(20):1471-2. PubMed ID: 9583981 [No Abstract] [Full Text] [Related]
42. Total glycolipid and glucosylceramide content in serum and urine of patients with Gaucher's disease type 3 before and after enzyme replacement therapy. Gornati R, Bembi B, Tong X, Boscolo R, Berra B. Clin Chim Acta; 1998 Mar 23; 271(2):151-61. PubMed ID: 9565330 [Abstract] [Full Text] [Related]
43. [French results of enzyme replacement therapy in Gaucher's disease]. Schaison G, Caubel I, Belmatoug N, Billette de Villemeur T, Saudubray JM. Bull Acad Natl Med; 2002 Mar 23; 186(5):851-61; discussion 861-3. PubMed ID: 12412377 [Abstract] [Full Text] [Related]
44. [Uveitis masquerade syndrome in Gaucher disease. Causal treatment by alglucerase substitution therapy]. Dann K, Althaus C, Kersten A, vom Dahl S, Sundmacher R. Klin Monbl Augenheilkd; 1998 Dec 23; 213(6):358-61. PubMed ID: 10048015 [Abstract] [Full Text] [Related]
46. Neurological features in Gaucher's disease during enzyme replacement therapy. Ono H, Fujiwara M, Ito K, Ueda H, Mizoguchi N, Sakura N. Acta Paediatr; 2001 Feb 23; 90(2):229-31. PubMed ID: 11236058 [Abstract] [Full Text] [Related]
47. Treatment of Gaucher's disease. Grabowski GA. N Engl J Med; 1993 May 27; 328(21):1565. PubMed ID: 8479497 [No Abstract] [Full Text] [Related]
48. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. Barton NW, Brady RO, Dambrosia JM, Di Bisceglie AM, Doppelt SH, Hill SC, Mankin HJ, Murray GJ, Parker RI, Argoff CE. N Engl J Med; 1991 May 23; 324(21):1464-70. PubMed ID: 2023606 [Abstract] [Full Text] [Related]
52. Individualised low-dose alglucerase therapy for type 1 Gaucher's disease. Hollak CE, Aerts JM, Goudsmit R, Phoa SS, Ek M, van Weely S, von dem Borne AE, van Oers MH. Lancet; 1995 Jun 10; 345(8963):1474-8. PubMed ID: 7769902 [Abstract] [Full Text] [Related]
53. [Gaucher's disease. Substitutive enzymatic treatment in one case and a review of the literature]. Rachid M, Harif M, Quessar A, Jabri L, Benchekroun S. Tunis Med; 2005 Jan 10; 83(1):43-7. PubMed ID: 15881721 [Abstract] [Full Text] [Related]
54. Total hip replacement in Gaucher's disease: effects of enzyme replacement therapy. Bubbar V, Heras FL, Amato D, Pritzker KP, Gross AE. J Bone Joint Surg Br; 2009 Dec 10; 91(12):1623-7. PubMed ID: 19949128 [Abstract] [Full Text] [Related]
55. Pulmonary hypertension in Gaucher's disease. Pastores GM, Miller A. Lancet; 1998 Aug 15; 352(9127):580. PubMed ID: 9716094 [No Abstract] [Full Text] [Related]
56. Subtotal splenectomy for Gaucher's disease: a follow-up study. Morgenstern L, Verham R, Weinstein I, Phillips EH. Am Surg; 1993 Dec 15; 59(12):860-5. PubMed ID: 8256944 [Abstract] [Full Text] [Related]
57. Gaucher's disease: a review for the internist and hepatologist. Niederau C, Häussinger D. Hepatogastroenterology; 2000 Dec 15; 47(34):984-97. PubMed ID: 11020862 [Abstract] [Full Text] [Related]
58. [Gaucher's disease. Forget the past?]. Giralt M, Félix DR. Sangre (Barc); 1994 Feb 15; 39(1):1-2. PubMed ID: 8197512 [No Abstract] [Full Text] [Related]
59. Enzyme replacement therapy in Gaucher's disease: a rapid, high-yield method for purification of glucocerebrosidase. Dale GL, Beutler E. Proc Natl Acad Sci U S A; 1976 Dec 15; 73(12):4672-4. PubMed ID: 1070017 [Abstract] [Full Text] [Related]